EyePoint Pharmaceuticals
EYPT
#6140
Rank
S$1.36 B
Marketcap
S$16.32
Share price
-3.14%
Change (1 day)
21.11%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2026 (TTM): -S$0.35 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are S$7.61 Million. In 2025 the company made an earning of -S$0.3 Billion a decrease over its 2024 earnings that were of -S$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.35 Billion15.78%
2025 -S$0.3 Billion63.24%
2024 -S$0.19 Billion104.29%
2023 -S$89.7 Million-29.88%
2022 -S$0.13 Billion87.2%
2021 -S$68.33 Million38.58%
2020 -S$49.31 Million-24.56%
2019 -S$65.36 Million
2017 -S$29.82 Million22.59%
2016 -S$24.32 Million-8.02%
2015 -S$26.44 Million-296.09%
2014 S$13.48 M-174.02%
2013 -S$18.22 Million37.42%
2012 -S$13.26 Million-56.29%
2011 -S$30.33 Million-1062.38%
2010 S$3.15 M-250.43%
2009 -S$2.1 Million-89.5%
2008 -S$19.96 Million
2005 -S$12.31 Million56.99%
2004 -S$7.84 Million73.7%
2003 -S$4.52 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-S$2.8 Million-99.20% Bahamas
NRC Health
NRC
S$25.33 M-107.26%๐Ÿ‡บ๐Ÿ‡ธ USA